Pan-Cancer Study Uncovers TP53 Mutation Consequences, Related Prognostic Expression Signature Published on Jul 30, 2019  Hazelden Betty Ford Foundation, Mayo Clinic to Study Pharmacogenomics of Alcoholism Treatment Published on Jul 30, 2019  Curetis Inks European Distribution Deals for MDx Products Published on Jul 30, 2019

Featured in Depth

Illumina Says Population Sequencing, DTC Will Continue to Grow in the Long Term Published on Jul 30, 2019

Exact Sciences Touts Advantages of Genomic Health Acquisition for Pipeline Development Published on Jul 29, 2019

Startup Credo Biomedical Launching Low-Cost Point-of-Care Influenza MDx Published on Jul 29, 2019

Tangen Biosciences Developing Lab-on-a-Disc Isothermal MDx for Point of Care Published on Jul 29, 2019

Beyond Cas9: CRISPR Gene Editing with Alternative Nucleases  In this webinar, Shondra Miller of St. Jude Children's Research Hospital will discuss the pros and cons of several Cas9 variants and orthologues and how these alternative nucleases can be applied to genome editing workflows. Register Now

Recommended for You

Anorexia GWAS Yields Risk Loci with Metabolic, Psychiatric Overlap Published on Jul 15, 2019